Bogart Wealth’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Hold
1
– – ﹤0.01% 2122
2026
Q2
$1 Hold
1
– – ﹤0.01% 2009
2026
Q1
$1 Buy
+1
New +$1 ﹤0.01% 1822

Other funds holding OGEN

Bogart Wealth's OGEN Position: Q3 2026 in Review

Bogart Wealth held its Oragenics (OGEN) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

Bogart Wealth first reported a position in OGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $1 in Q2 2026. 17 funds tracked by Wall St. Rank hold OGEN as of Q3 2026.

  • Bogart Wealth held 1 share of Oragenics worth $0 as of Q3 2026.
  • Bogart Wealth left its Oragenics share count unchanged in Q3 2026.
  • Oragenics made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #2122 holding.
  • Bogart Wealth first reported a position in Oragenics in Q1 2026 and has held it in 3 quarters since.
  • Bogart Wealth's Oragenics position peaked at $1 in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.